Respondents in Germany who think they have been exposed to the disease – either through showing symptoms, because they might have recently been in contact with someone with the disease, or both – are more likely than the population as a whole to favur to believe that their country should have priority access to a vaccine developed there. As the severity of exposure increase, so too does this likelihood. What about you? Do you think any country should have priority access to a vaccine? Should it be made available to the places with the worst infection rates first? Or should it be made available everywhere? Let us know by taking the survey.
Chart by Visualizer